JP2022512921A5 - - Google Patents

Info

Publication number
JP2022512921A5
JP2022512921A5 JP2021524058A JP2021524058A JP2022512921A5 JP 2022512921 A5 JP2022512921 A5 JP 2022512921A5 JP 2021524058 A JP2021524058 A JP 2021524058A JP 2021524058 A JP2021524058 A JP 2021524058A JP 2022512921 A5 JP2022512921 A5 JP 2022512921A5
Authority
JP
Japan
Prior art keywords
primate
cell differentiation
composition according
hair cell
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021524058A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022512921A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/060324 external-priority patent/WO2020097369A1/en
Publication of JP2022512921A publication Critical patent/JP2022512921A/ja
Publication of JP2022512921A5 publication Critical patent/JP2022512921A5/ja
Pending legal-status Critical Current

Links

JP2021524058A 2018-11-07 2019-11-07 有毛細胞の分化を誘導する組成物及び方法 Pending JP2022512921A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862756910P 2018-11-07 2018-11-07
US62/756,910 2018-11-07
US201962888105P 2019-08-16 2019-08-16
US62/888,105 2019-08-16
PCT/US2019/060324 WO2020097369A1 (en) 2018-11-07 2019-11-07 Compositions and methods of inducing differentiation of a hair cell

Publications (2)

Publication Number Publication Date
JP2022512921A JP2022512921A (ja) 2022-02-07
JP2022512921A5 true JP2022512921A5 (enExample) 2022-12-28

Family

ID=70611182

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021524058A Pending JP2022512921A (ja) 2018-11-07 2019-11-07 有毛細胞の分化を誘導する組成物及び方法

Country Status (7)

Country Link
US (1) US20220395582A1 (enExample)
EP (1) EP3880827A4 (enExample)
JP (1) JP2022512921A (enExample)
CN (1) CN113874512A (enExample)
AU (1) AU2019376084A1 (enExample)
CA (1) CA3119059A1 (enExample)
WO (1) WO2020097369A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12600943B2 (en) 2019-02-01 2026-04-14 The University Of Hong Kong Innervated organoid compositions and methods of making same
US12497597B2 (en) 2019-05-31 2025-12-16 Children's Hospital Medical Center Methods of generating and expanding hematopoietic stem cells
AU2020283048A1 (en) 2019-05-31 2021-12-23 Children's Hospital Medical Center Shaped organoid compositions and methods of making same
KR20230061333A (ko) * 2020-06-23 2023-05-08 칠드런즈 호스피탈 메디칼 센터 인슐린 저항성 모델
KR20240021166A (ko) * 2021-05-05 2024-02-16 데시벨 테라퓨틱스, 인크. 스테레오실린 이중 벡터 시스템을 사용하여 감각신경성 청력 상실을 치료하기 위한 조성물 및 방법
US20250073354A1 (en) * 2021-12-23 2025-03-06 University Of Rochester Compositions and methods for delivery of agents to inner ear
WO2025094056A1 (en) * 2023-10-31 2025-05-08 Children's Medical Research Institute Gene therapy constructs and methods of use therefor

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0203035A3 (en) * 1998-07-14 2007-12-28 Corixa Corp Compositions and methods for therapy and diagnosis of prostate cancer
US20040166091A1 (en) * 2003-02-24 2004-08-26 Genvec, Inc. Materials and methods for treating disorders of the ear
EP1755400A2 (en) * 2004-06-18 2007-02-28 The University Of Montana Aav mediated gene delivery to cochlear cells
CA2801535C (en) * 2010-06-04 2017-05-30 Hough Ear Institute Composition and method for inner ear sensory hair cell regeneration or replacement
BR112014002638A2 (pt) * 2011-08-03 2017-02-21 Quark Pharmaceuticals Inc compostos de oligonucleo tídeo de fita dupla para tratar desordens de audição e equilíbrio
AU2014255665B2 (en) * 2013-04-18 2018-08-02 Fondazione Telethon Effective delivery of large genes by dual AAV vectors
JP2015534818A (ja) * 2013-11-04 2015-12-07 ジェネシス リサーチ インスティチュート 聴覚を治療するための組成物および方法
SG10201913266UA (en) * 2015-12-11 2020-02-27 Massachusetts Eye & Ear Infirmary Materials and methods for delivering nucleic acids to cochlear and vestibular cells
JP7007273B2 (ja) * 2015-12-22 2022-01-24 アンセルム(アンスティチュート・ナシオナル・ドゥ・ラ・サンテ・エ・ドゥ・ラ・ルシェルシュ・メディカル) 遺伝子治療用の改良された複合型二重組換えaavベクターシステム
WO2017136764A1 (en) * 2016-02-05 2017-08-10 The General Hospital Corporation Hybrid system for efficient gene delivery to cells of the inner ear
US20190142969A1 (en) * 2016-04-26 2019-05-16 Massachusetts Eye And Ear Infirmary ISL1-Based Gene Therapy to Treat Hearing Loss
EP3510161A4 (en) * 2016-08-23 2020-04-22 Akouos, Inc. COMPOSITIONS AND METHODS FOR TREATING PERSONAL HEARING LOSS IN A PERSON
WO2020077295A1 (en) * 2018-10-11 2020-04-16 Decibel Therapeutics, Inc. Aav1 vectors and uses thereof for treatment of otic indications
CN110437317B (zh) * 2019-01-30 2023-05-02 上海科技大学 具有变异衣壳蛋白的腺相关病毒及其用途

Similar Documents

Publication Publication Date Title
JP2022512921A5 (enExample)
JP2021513863A5 (enExample)
US20240131093A1 (en) Compositions and methods of treating huntington's disease
EP3404106B1 (fr) Systeme d'expression pour une therapie genique selective
US12024728B2 (en) Methods and compositions for modulating a genome
JP7413256B2 (ja) 神経変性疾患の遺伝子治療
US20240415868A1 (en) Compositions and methods for treating huntington's disease
US20240325427A1 (en) Treatment of amyotrophic lateral sclerosis (als)
CN118910166A (zh) 调节性多核苷酸
AU2023217698A1 (en) Aav capsid variants and uses thereof
US20210254103A1 (en) Treatment of amyotrophic lateral sclerosis and disorders associated with the spinal cord
US20230399642A1 (en) Compositions and methods of treating huntington's disease
JP2021530227A5 (enExample)
KR20210096168A (ko) 신경퇴행성 질환을 위한 유전자 요법
CN119137273A (zh) 包括工程化核内小RNA(snRNA)的组合物和方法
CA3259902A1 (en) AAV Capsid Variants and Their Uses
WO2017151717A1 (en) Compositions and methods for adeno-associated virus mediated gene expression in myofibroblast-like cells
CN115806984A (zh) 环状rna及载体和载体的应用
IL311223A (en) Recruitment in trans of gene editing system components
CN115443154A (zh) 用于基因上调的miRNA-485抑制剂
CN115867290A (zh) 用于亨廷顿病的mirna-485抑制剂
TW202504620A (zh) 用於治療cag重複疾病之組成物和方法
TW202444915A (zh) Serpina調節組合物及方法
JP7853297B2 (ja) Ild、pf-ildおよびipf治療用ウイルスベクターおよび核酸
WO2026032020A1 (zh) Aav介导的rpgr x连锁视网膜变性的基因编辑治疗方法